MedicalResearch.com |

27 Jul Scientists Develop New Therapy for HER2-Positive Breast Cancer

Posted at 10:38h in Breast Cancer, Cancer Research

Newswise — PHILADELPHIA — Patients with HER2-positive breast cancer may have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Jacek Capala, Ph.D., D.Sc., an investigator at the...

26 Jul Hormone therapy may be hazardous for men with heart conditions

Posted at 18:00h in Cancer Research, Hormone Therapy, Prostate Cancer

Fairfax, Va., July 26, 2011 – Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk...

26 Jul New Avenues Open Up for Mesothelioma Targeted Therapy

Posted at 00:12h in Cancer Research

Newswise — July 25, 2011 (Philadelphia, PA) --Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors. Scientists tested...

25 Jul Study examines screening for pancreatic cancer in high-risk populations

Posted at 19:43h in Cancer Research, Dartmouth

OAK BROOK, Ill. – July 25, 2011 – Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than...

24 Jul 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma

Posted at 23:01h in Cancer Research, Nature, Sloan Kettering, University of Pennsylvania

A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced second cancers years after treatment. Knowing in advance who is at risk could help physicians tailor treatment to...

Cancer Research

27 Jul Scientists Develop New Therapy for HER2-Positive Breast Cancer

26 Jul Hormone therapy may be hazardous for men with heart conditions

26 Jul New Avenues Open Up for Mesothelioma Targeted Therapy

25 Jul Study examines screening for pancreatic cancer in high-risk populations

24 Jul 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma

Pages